Literature DB >> 11745954

Presymptomatic motor neuron loss and reactive astrocytosis in the SOD1 mouse model of amyotrophic lateral sclerosis.

S J Feeney1, P A McKelvie, L Austin, M J Jean-Francois, R Kapsa, S M Tombs, E Byrne.   

Abstract

In familial amyotrophic lateral sclerosis (fALS), there is a need to establish more precisely the progression of the disease, particularly whether there is gradual presymptomatic neuronal loss or an abrupt loss coinciding with the symptomatic stage. To elucidate this, we investigated the progression of motor neuron loss through morphological techniques, reactive astrocytosis, and expression of ubiquitin and neurofilament proteins, by immunohistochemistry, in SOD1 G93A mice with a protracted disease course and control mice. Loss of motor neurons in SOD1 G93A mice followed a biphasic progression, with an initial loss at 126 days of age, followed by a gradual loss from onset of symptoms through to end-stage disease. Reactive astrocytosis was first observed at 70 days of age and showed a gradual increase through to end-stage disease. This suggests that there is a need for early detection of fALS cases, and potential therapeutic treatments may be more beneficial if administered at an early stage. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745954     DOI: 10.1002/mus.1176

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  23 in total

1.  Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model.

Authors:  Cynthia P W Soon; Paul S Donnelly; Bradley J Turner; Lin W Hung; Peter J Crouch; Nicki A Sherratt; Jiang-Li Tan; Nastasia K-H Lim; Linh Lam; Laura Bica; SinChun Lim; James L Hickey; Julia Morizzi; Andrew Powell; David I Finkelstein; Janetta G Culvenor; Colin L Masters; James Duce; Anthony R White; Kevin J Barnham; Qiao-Xin Li
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

2.  Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations.

Authors:  Sydney K Vaughan; Zachary Kemp; Theo Hatzipetros; Fernando Vieira; Gregorio Valdez
Journal:  J Comp Neurol       Date:  2015-07-21       Impact factor: 3.215

Review 3.  Modulators of nucleoside metabolism in the therapy of brain diseases.

Authors:  Detlev Boison
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Yan Su Guo; Dong Xia Wu; Hong Ran Wu; Shu Yu Wu; Cheng Yang; Bin Li; Hui Bu; Yue Sheng Zhang; Chun Yan Li
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

5.  Motor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes.

Authors:  Nizar Souayah; Joseph G Potian; Carmen C Garcia; Natalia Krivitskaya; Christine Boone; Vanessa H Routh; Joseph J McArdle
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

6.  Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients.

Authors:  Karin Forsberg; P Andreas Jonsson; Peter M Andersen; Daniel Bergemalm; Karin S Graffmo; Magnus Hultdin; Johan Jacobsson; Roland Rosquist; Stefan L Marklund; Thomas Brännström
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

7.  Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial.

Authors:  Elijah W Stommel; Jeffrey A Cohen; Camilo E Fadul; Christopher H Cogbill; David J Graber; Linda Kingman; Todd Mackenzie; Jacqueline Y Channon Smith; Brent T Harris
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

8.  Reductions in motor unit number estimates (MUNE) precede motor neuron loss in the plasma membrane calcium ATPase 2 (PMCA2)-heterozygous mice.

Authors:  Nizar Souayah; Anna Sharovetskaya; Michael P Kurnellas; Matthew Myerson; Jeffrey S Deitch; Stella Elkabes
Journal:  Exp Neurol       Date:  2008-09-19       Impact factor: 5.330

9.  Head injury and amyotrophic lateral sclerosis.

Authors:  Honglei Chen; Marie Richard; Dale P Sandler; David M Umbach; Freya Kamel
Journal:  Am J Epidemiol       Date:  2007-07-19       Impact factor: 4.897

10.  Neuron-astrocyte interactions in neurodegenerative diseases: Role of neuroinflammation.

Authors:  Kakulavarapu V Rama Rao; Tammy Kielian
Journal:  Clin Exp Neuroimmunol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.